Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07211763

Comparison of Transcutaneous and Arterial Carbon Dioxide Sampling During Jet Ventilation, a Prospective. Study on Patients Undergoing Percutaneous Liver Tumour Radiofrequency Ablation

Transcutaneous Versus Arterial Carbon Dioxide Monitoring During Jet Ventilation

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Sahlgrenska University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study aims to compare the readings from two methods of monitoring carbon dioxide levels during jet ventilation when normal end-tidal monitoring is not possible. During jet ventilation it is technically not possible to monitor the levels of carbon dioxide in exhaled air as is the standard in preoperative care. We will compare transcutaneous (through the skin) monitoring to an arterial blood. sample. Both transcutaneous monitoring and arterial monitoring is currently used as the standard for this patient group at our institution. By collecting data prospectively we can evaluate if there. are discrepancies based on monitoring method. All patients will be treated per standard preoperative protocol and only patients consenting to participate will contribute data to the comparison and statistical analysis.

Detailed description

During percutaneous radio frequency ablation of liver tumours, jet. ventilation is used to minimise diaphragm movement. By not having conventional ventilation the interventional radiologist have better conditions to perform the treatment and minimising risk damaging adjacent tissue. Jet ventilation does however remove the possibility to monitor end tidal CO2, necessitating alternative monitoring to ensure adequate ventilation. At our institution we use transcutaneous and arterial blood gas monitoring. We aim to collect data on both modalities and compare the values using a "repeat measure Bland-Altmann" analysis. Study participants will be managed as per normal protocol and the only difference to the non-participators will be their contribution of prospective data for later analysis.

Conditions

Interventions

TypeNameDescription
OTHERNo InterventionsNo intervention, solely data collection

Timeline

Start date
2025-04-01
Primary completion
2026-06-01
Completion
2026-07-01
First posted
2025-10-08
Last updated
2025-10-08

Locations

1 site across 1 country: Sweden

Regulatory

Source: ClinicalTrials.gov record NCT07211763. Inclusion in this directory is not an endorsement.